Collegium [COLL] vs Haleon Plc - ADR [HLN] Detailed Stock Comparison

Collegium Pharmaceutical Inc.

NASDAQ
Loading...

Haleon Plc - ADR

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Collegium Pharmaceutical Inc. wins in 12 metrics, Haleon Plc - ADR wins in 8 metrics, with 0 ties. Collegium Pharmaceutical Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Collegium Pharmaceutical Inc. Haleon Plc - ADR Better
P/E Ratio (TTM) 18.79 18.72 Haleon Plc - ADR
Price-to-Book Ratio 3.42 1.88 Haleon Plc - ADR
Debt-to-Equity Ratio 310.41 52.37 Haleon Plc - ADR
PEG Ratio 0.49 15.42 Collegium Pharmaceutical Inc.
EV/EBITDA 3.77 33.08 Collegium Pharmaceutical Inc.
Profit Margin (TTM) 8.05% 15.11% Haleon Plc - ADR
Operating Margin (TTM) 30.04% 23.17% Collegium Pharmaceutical Inc.
EBITDA Margin (TTM) 30.04% 23.17% Collegium Pharmaceutical Inc.
Return on Equity 23.70% 10.27% Collegium Pharmaceutical Inc.
Return on Assets (TTM) 7.27% 4.67% Collegium Pharmaceutical Inc.
Free Cash Flow (TTM) $327.58M $2.22B Haleon Plc - ADR
Dividend Yield N/A 1.63% N/A
1-Year Return 15.34% -20.18% Collegium Pharmaceutical Inc.
Price-to-Sales Ratio (TTM) 1.35 3.78 Collegium Pharmaceutical Inc.
Enterprise Value $1.58B $122.54B Haleon Plc - ADR
EV/Revenue Ratio 2.03 8.23 Collegium Pharmaceutical Inc.
Gross Profit Margin (TTM) 62.49% 55.38% Collegium Pharmaceutical Inc.
Revenue per Share (TTM) $25 $2 Collegium Pharmaceutical Inc.
Earnings per Share (Diluted) $1.73 $0.50 Collegium Pharmaceutical Inc.
Beta (Stock Volatility) 0.77 0.33 Haleon Plc - ADR
Short % of Float 22.26% 0.43% Haleon Plc - ADR

Collegium Pharmaceutical Inc. vs Haleon Plc - ADR Stock Performance Analysis

Loading Price Chart...

COLL
HLN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Collegium Pharmaceutical Inc.1.90%-7.78%-10.18%-22.33%-35.09%-31.78%
Haleon Plc - ADR0.23%-6.44%-5.63%-17.81%-8.31%-12.80%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Collegium Pharmaceutical Inc.15.34%55.39%54.10%108.37%159.54%159.54%
Haleon Plc - ADR-20.18%9.16%22.27%22.27%22.27%22.27%

Performance & Financial Health Analysis: Collegium Pharmaceutical Inc. vs Haleon Plc - ADR

MetricCOLLHLN
Market Information
Market Cap i$1.05B$42.40B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i492,2206,594,249
90 Day Avg. Volume i584,0777,985,230
Last Close$31.06$8.72
52 Week Range$28.90 - $50.79$8.65 - $11.30
% from 52W High-38.84%-22.83%
All-Time High$50.79 (Dec 29, 2025)$11.42 (Jun 02, 2025)
% from All-Time High-38.85%-23.64%
Growth Metrics
Quarterly Revenue Growth0.13%0.01%
Quarterly Earnings Growth0.35%0.86%
Financial Health
Profit Margin (TTM) i0.08%0.15%
Operating Margin (TTM) i0.30%0.23%
Return on Equity (TTM) i0.24%0.10%
Debt to Equity (MRQ) i310.4152.37
Cash & Liquidity
Book Value per Share (MRQ)$9.51$4.99
Cash per Share (MRQ)$12.18$0.15
Operating Cash Flow (TTM) i$329.32M$3.56B
Levered Free Cash Flow (TTM) i$321.54M$1.89B
Dividends
Last 12-Month Dividend Yield iN/A1.63%
Last 12-Month Dividend iN/A$0.17

Valuation & Enterprise Metrics Analysis: Collegium Pharmaceutical Inc. vs Haleon Plc - ADR

MetricCOLL (Apr 26, 2026)HLN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i18.7918.72
Forward P/E i4.8215.42
PEG Ratio i0.4915.42
Price to Sales (TTM) i1.353.78
Price to Book (MRQ) i3.421.88
Market Capitalization
Market Capitalization i$1.05B$42.40B
Enterprise Value i$1.58B$122.54B
Enterprise Value Metrics
Enterprise to Revenue i2.038.23
Enterprise to EBITDA i3.7733.08
Risk & Other Metrics
Beta i0.770.33
Book Value per Share (MRQ) i$9.51$4.99

Financial Statements Comparison: Collegium Pharmaceutical Inc. vs Haleon Plc - ADR

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCOLL (2025)HLN (2025)
Revenue/Sales i780.57M11.03B
Cost of Goods Sold i317.31M3.95B
COGS % of Revenue i40.7%35.8%
Gross Profit i463.26M7.08B
Gross Margin i59.3%64.2%
Research & Development iN/A316.00M
Operating Income (EBIT) i178.45M2.41B
Operating Margin i22.9%21.9%
EBITDA i415.82M2.81B
EBITDA Margin i53.3%25.5%
Pre-Tax Income i92.62M2.15B
Pre-Tax Income % of Revenue i11.9%19.5%
Income Tax i29.75M472.00M
Income Tax % of Revenue i3.8%4.3%
Net Income (Profit) i62.87M1.68B
Profit Margin i8.1%15.2%

Balance Sheet & Liquidity Metrics

MetricCOLL (2025)HLN (2025)
Cash & Equivalents i231.25M1.26B
Total Current Assets i691.41M4.55B
Total Current Assets % of Revenue i88.6%41.3%
Total Current Liabilities i440.03M4.93B
Total Current Liabilities % of Revenue i56.4%44.7%
Long-Term Debt i784.46M7.75B
Long-Term Debt % of Revenue i100.5%70.2%
Total Shareholders Equity i301.68M16.48B
Retained Earnings i-101.13M27.85B
Retained Earnings % of Revenue i-13.0%252.5%
Property, Plant & Equipment i25.77M1.00M

Cash Flow Statement Comparison

MetricCOLL (2025)HLN (2025)
Operating Cash Flow i329.01M2.19B
Operating Cash Flow % of Revenue i42.2%19.8%
Capital Expenditures i-1.74M-322.00M
Free Cash Flow i327.58M2.22B
FCF Margin i42.0%20.1%
Debt Repayment i-635.56M-1.35B
Common Stock Repurchase i-25.10M-654.00M

Short Interest & Institutional Ownership Analysis

MetricCOLLHLN
Shares Short i6.03M19.28M
Short Ratio i9.322.14
Short % of Float i22.26%0.43%
Shares Outstanding i31.71M8.91B
Float Shares i31.30M8.86B
% Held by Insiders i0.94%0.01%
% Held by Institutions i120.97%12.74%
% Held by Public i-21.91%87.25%

Dividend Analysis & Yield Comparison: Collegium Pharmaceutical Inc. vs Haleon Plc - ADR

MetricCOLLHLN
Last 12-Month Dividend iN/A$0.17
Last 12-Month Dividend Yield iN/A1.63%
3-Year Avg Annual Dividend iN/A$0.11
3-Year Avg Dividend Yield iN/A0.91%
3-Year Total Dividends iN/A$0.34
Ex-Dividend DateN/AApr 25, 2025